Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
247 3 |
Ultima descărcare din IBN: 2024-03-19 11:43 |
SM ISO690:2012 EFREMOVA, Daniela, CIOBANU, Natalia, GLAVAN, Danu, LEAHU, Pavel, RĂCILĂ, Renata, BĂLĂNUȚĂ, Tatiana, MATEI, Alexandru, VASILIEVA, Maria, CHEPTEA, Cristina, BÎTCĂ, Paula, DAMIAN, Cristina, BONDARCIUC, Ana, BEJENARI, Irina, COJOCARU, Adelina, MANEA, Diana, CIOCANU, Mihail, ZOTA, Eremei, CIOLAC, Dumitru, GROPPA, Stanislav. Serum Urate Levels and Ultrasound Characteristics of Carotid Atherosclerosis across Obesity Phenotypes. In: Biomedicines, 2023, vol. 11, pp. 1-12. ISSN -. DOI: https://doi.org/10.3390/biomedicines11071897 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Biomedicines | ||||||
Volumul 11 / 2023 / ISSN - /ISSNe 2227-9059 | ||||||
|
||||||
DOI:https://doi.org/10.3390/biomedicines11071897 | ||||||
Pag. 1-12 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background: Existing evidence suggests a close link among high levels of serum urate (SU), obesity and carotid atherosclerosis. The aim of the present study was to evaluate the interrelations between SU levels and carotid atherosclerosis in subjects with different obesity phenotypes. Methods: In this study, a total of 2076 subjects (mean age 48.1 ± 13.1 years; 1307 women) were recruited: 59 with general obesity, 616 with central obesity, 715 with mixed (general–central) obesity and 686 non-obese. Anthropometric measurements, vascular risk factors, blood biochemistry analysis (including SU levels), and carotid ultrasound were performed. Ultrasound assessment included evaluation of intima-media thickness (IMT) and plaque characteristics, including number, total area and type (vulnerable vs. stable) of plaques. Results: After adjustment for potential confounders, the highest levels of SU were observed in subjects with mixed obesity, followed by subjects with central obesity, general obesity and the non-obese (309.4 ± 82.2 vs. 301.2 ± 73.1 vs. 272.9 ± 61.8 vs. 234.2 ± 59.8 μmol/L, respectively; F = 149.2, post hoc p < 0.001). Similarly, subjects with mixed and central obesity presented higher values of IMT compared to subjects with general obesity and the non-obese (0.68 ± 0.16 vs. 0.67 ± 0.16 vs. 0.62 ± 0.14 vs. 0.57 ± 0.13 mm, respectively; F = 54.2, post hoc p < 0.001). No difference in number, total area and type of plaques among obesity groups were attested (all p > 0.05). Significantly higher IMT values were observed in subjects with increased SU levels compared to subjects with normal SU levels (0.70 ± 0.10 vs. 0.62 ± 0.14 mm, p = 0.02) only within the central obesity group. Increasing levels of SU were associated with a higher frequency of increased IMT only in subjects with central obesity (OR 1.033, 95% CI 1.025–1.041). Similarly, SU levels yielded a satisfactory performance in detecting subjects with increased IMT (AUC 0.65, 95% CI 0.50–0.73, subjects with carotid plaques (0.62, 95% CI 0.55–0.68) and subjects with vulnerable plaque types (0.68, 0.59–0.76) only within the central obesity group. Conclusions: Among the studied obesity types, the association between SU levels and markers of carotid atherosclerosis was of particular significance in subjects with central obesity. |
||||||
Cuvinte-cheie carotid plaques, intima-media thickness, obesity phenotype, serum urate |
||||||
|